The Hyper-Aligned Partnership Event Delivering Better Access to Global Big Pharma Seeking Innovation in Asia
With fast, cost-effective clinical infrastructure, generous government incentives, and simplified regulatory pathways, Asia’s biotech ecosystem has emerged as a global launchpad for innovation. Western pharma and biotech companies are increasingly turning to de-risked assets from Asia to supercharge their clinical pipelines and gain a competitive edge.
Already running in the US, the Targeted Therapies Partnering & Licensing Summit Asia is built to gather a regional, critical mass of ADC, Bispecific Antibody, T-Cell Engager, Targeted Protein Degradation, and Radiopharmaceutical platforms and pipelines, so that global multi-national (MNC) pharma can connect with biotech business development and discuss new licensing and co-development opportunities.
For NewCo, private and public biotech or small pharma, this accessible forum offers:
- High seniority and quality of attendees across pharma and other biotech
- Targeted focus, purpose-built format, and One-on-One Partnering™ portal allowing you to make meaningful connections easier and more efficient
- Informative presentations and discussions nuanced to considerations for deal-making across targeted therapies
Global exposure, local advantage. Pharma can assess related programs back-to-back and biotech can meet multiple, international big pharma.
The focused niche really increased the impact for us overall. Thanks for including us in the program.
Executive Director, Business Development, Roche
It was stellar; I heard this sentiment echoed throughout. We appreciated the focused yet expansive discussions and talks in a more intimate setting, allowing for easier networking, too.
Executive Director, Business Development, BMS
I thought it was fantastic - operationally excellent and thoughtfully designed.
Executive Director, Business Development, Merck
It was a great group of high-quality companies/people in the perfect setting.
Executive Director, Business Development, J&J
I like the format. It meant the companies knew what Sanofi was looking for and made the 30-minute meetings very efficient.
Executive Director, Business Development, Sanofi
Explore the Full Event Guide
- 100% alignment across research focus, business needs and individual responsibilities
- Global pharma business development panel discussion to hear pharma’s wants and needs
- Asia investors' formal networking session to understand the excitement around investing
- Informal drinks and networking reception to connect with other attendees
- Learn from peers across DCs, TPD, BsAbs, TCEs and RLTs
How is this Networking Format Delivered?
Day One Pharma Icebreaker Panel & Matchmaking
With a high representation for pharma due diligence teams, first understand what MNCs are seeking to in-license – from differentiation that stimulates interest, to tumor types or stage of asset. Second, introduce yourself to all of pharma in attendance during the pharma matchmaking session, so you can arrange to follow up later at the conference. And, finally, have private 1-2-1 meetings with multiple pharma, so you can share your pitch deck and receive dedicated feedback. Multiple guaranteed meetings, without having to cut through the noise.
Focused & Relevant Content Across Panel Discussions
Uniting adjacent markets across ADCs, Targeted Antibodies, Protein Degradation and Radioisotopes, leverage insights into innovation and successful partnerships from across industries, to understand how success of one leading to success of the others across panel discussions with industry leaders.
Short Company Presentations to Pitch to Pharma in Attendance
Register to present in one of the limited 15-minute presentation slots, to take advantage of the full engagement of pharma attending. Stir up interest in advance with complimentary branding on the website and host your logo at the event, alongside other innovators in the field.
Attending Companies Include
